» Articles » PMID: 10323886

Expression and Activity of Mitogen Activated Protein Kinases in Human Colorectal Carcinoma

Overview
Journal Gut
Specialty Gastroenterology
Date 1999 May 14
PMID 10323886
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Mitogen activated protein kinases (MAPKs) play a central role in the regulation of both cell growth and differentiation. They are involved in signal transduction of oncogenes and growth factors. The role of MAPK in colonic carcinoma is unknown.

Aims: To establish whether the expression and activity of p42/44 MAPKs are altered in colorectal tumours as compared with normal mucosa.

Methods: The expression and activity of p42/p44 MAPK were investigated in 22 colorectal carcinomas, four adenomas, and the corresponding normal colorectal mucosa by the use of western blotting, immunoprecipitation, and in vitro kinase assays.

Results: After immunoprecipitation with an antibody specific for p42 MAPK, we found significant inactivation of p42 MAPK in colonic carcinomas as well as in adenomas, whereas most sample pairs showed only minor differences in p42 MAPK expression. Investigation of MAPK with an antibody capable of detecting both p42 and p44 MAPK showed a slight but significant decrease in p44 MAPK content in malignant tissues. With this antibody, only minor alterations in MAPK activity and no correlation with p42 MAPK activity were found.

Conclusions: Inactivation of p42 MAPK could be associated with colonic carcinogenesis.

Citing Articles

Ku70 senses cytosolic DNA and assembles a tumor-suppressive signalosome.

Pandey A, Shen C, Feng S, Enosi Tuipulotu D, Ngo C, Liu C Sci Adv. 2024; 10(4):eadh3409.

PMID: 38277448 PMC: 10816715. DOI: 10.1126/sciadv.adh3409.


ERK2 Is a Promoter of Cancer Cell Growth and Migration in Colon Adenocarcinoma.

Parascandolo A, Benincasa G, Corcione F, Laukkanen M Antioxidants (Basel). 2024; 13(1).

PMID: 38247543 PMC: 10812609. DOI: 10.3390/antiox13010119.


KRAS mutation-independent downregulation of MAPK/PI3K signaling in colorectal cancer.

Lam K, Tang C, Tan E, Wong S, Cheah P Mol Oncol. 2021; 16(5):1171-1183.

PMID: 34919787 PMC: 8895447. DOI: 10.1002/1878-0261.13163.


Oncogenic KRAS signalling promotes the Wnt/β-catenin pathway through LRP6 in colorectal cancer.

Lemieux E, Cagnol S, Beaudry K, Carrier J, Rivard N Oncogene. 2014; 34(38):4914-27.

PMID: 25500543 PMC: 4687460. DOI: 10.1038/onc.2014.416.


Met receptor-induced Grb2 or Shc signals both promote transformation of intestinal epithelial cells, albeit they are required for distinct oncogenic functions.

Pomerleau V, Landry M, Bernier J, Vachon P, Saucier C BMC Cancer. 2014; 14:240.

PMID: 24708867 PMC: 4234027. DOI: 10.1186/1471-2407-14-240.


References
1.
Troppmair J, Bruder J, App H, Cai H, Liptak L, Szeberenyi J . Ras controls coupling of growth factor receptors and protein kinase C in the membrane to Raf-1 and B-Raf protein serine kinases in the cytosol. Oncogene. 1992; 7(9):1867-73. View

2.
Kyriakis J, App H, Zhang X, Banerjee P, Brautigan D, Rapp U . Raf-1 activates MAP kinase-kinase. Nature. 1992; 358(6385):417-21. DOI: 10.1038/358417a0. View

3.
Nishida E, Gotoh Y . The MAP kinase cascade is essential for diverse signal transduction pathways. Trends Biochem Sci. 1993; 18(4):128-31. DOI: 10.1016/0968-0004(93)90019-j. View

4.
Davis R . The mitogen-activated protein kinase signal transduction pathway. J Biol Chem. 1993; 268(20):14553-6. View

5.
Ward Y, Gupta S, Jensen P, Wartmann M, Davis R, Kelly K . Control of MAP kinase activation by the mitogen-induced threonine/tyrosine phosphatase PAC1. Nature. 1994; 367(6464):651-4. DOI: 10.1038/367651a0. View